Advertisement

Protective roles of crude and fractions of A. senegalensise carpel against alloxan-induced hyperglycemia and hyperlipidemia in rats

  • Sophia Shekwoyan MaikaiEmail author
  • Rofiyat Omolara Raji
  • Hadiza Lami Muhammad
  • Abdulkadir Abubakar
Original Article
  • 11 Downloads

Abstract

Medicinal plants are increasingly been investigated for potentials to provides active, safe and cost-effective alternative to synthetic antidiabetics. In the present study, hypoglycemic and hypolipidemic activities of crude methanol, hexane and ethylacetate fractions of Annona senegalensis (A. senegalensis) in alloxan-induced diabetic rats were evaluated. The extract and fractions of A. senegalensis were administered to alloxan (120 mg/kg bw) induced diabetic rats at doses of 100, 300 and 600 mg/kg bw. Glibenclamide (5 mg/kg bw) was used as the reference drug. All treatments were administered daily for 14 days through oral route with the aid of esophageal cannula. Effect of the treatments on blood glucose levels, body weight, packed cell volume (PCV) and lipid profiles were monitored. The crude extract had significantly (p < 0.05) higher percentage glucose reduction range of 71.61 ± 2.34% and 75.59 ± 1.09% when compared with the metformin (69.15 ± 2.90%). Ethyl acetate and n-hexane fractions had reduction range of 60.17 ± 3.56 to 67.74 ± 2.67, and 55.63 ± 1.09% to 68.05 ± 2.98% respectively. The crude extract and fractions of A. senegalensis significantly (p < 0.05) decreases the serum concentrations of cholesterol, triglycerides, low-density lipoprotein-cholesterol and increase high-density lipoprotein-cholesterol when compared with diabetic untreated rats. The serum total cholesterol and triglyceride in rats treated with 100 and 300 mg/kg n-hexane and those treated with ethylacetate fractions were comparable (p > 0.05) with the normal control rats but significantly (p < 0.05) lower than those treated with 600 mg/kg bw of the fractions and crude extract (100, 300 and 600 mg/kg bw). A. senegalensis carpel contains significant amount of phytochemicals with hypoglycemic reputation. The crude extract, ethylacetate and hexane fractions exhibited dose-dependent hypoglycemic and hypolipidemic activity in alloxan-induced diabetic rats.

Keywords

Annona senegalensis Hypolipidemic Hypoglycemic Diabetics Alloxan 

Notes

Acknowledgements

The authors would like to appreciate the technical staff of Biochemistry laboratory and animal house holding unit of Federal University of Technology Minna, for their kind assistances.

Funding information

No source of funding.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national and/or institutional guidelines for the care and use of animals were followed.

References

  1. Bamidele O, Arokoyo DS, Akinnuga AM, Oluwarole AO (2014) Anti-diabetic effect of aqueous extract of Basella alba leaves and metformin in alloxan induced diabetic albino rats. Afr J Biotechnol 13(24):2455–2458CrossRefGoogle Scholar
  2. Berinyuy EB, Lawal B, Olalekan AA, Olalekan AA, Yusuf AA, Sakpe S, Ossai PC (2015) Hematological status and organs/body-weight parameters in Wister rats during chronic administration of Cassia occidentalis. Int Blood Res Rev 4(3):1–7CrossRefGoogle Scholar
  3. Canadian Council on Animal Care (1997) Guide to the Care and Use of Experimental Animals. Vol. 1, 2nd Edn., 212 pp. Ottawa ON: CCACGoogle Scholar
  4. Chedi BAZ, Abubakar JG, Adoum OA (2017) Acute toxicity and antihyperglycaemic effect of ethanol stem-bark extract of Annona senegalensis Pers. (Annonaceae) on alloxan induced diabetic rats. Afr. J Pharmacol Ther 6(3):155–160Google Scholar
  5. Daisy P, Balasubramanian K, Rajalakshmi M, Eliza J, Selvaraj J (2010) Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin induced diabetic Wistar rats. Phytomed 17:28–36CrossRefGoogle Scholar
  6. Etuk EU (2010) Animals models for studying diabetes mellitus. Agric Biol J 1(2):130–134Google Scholar
  7. Francis G, Kerem Z, Makkar HP, Becker K (2002) The biological action of saponins in animal systems: a review. Br J Nutr 88:587–605CrossRefGoogle Scholar
  8. Freshet A, Daniel S, Eyasu M (2017) Antihyperglycemic and antihyperlipidemic activities of ethanol extract of Ajuga remota Benth (Harmegusa) leaves in streptozotocin induced diabetic rats. Afr J Pharm Pharmacol 11(2):17–24CrossRefGoogle Scholar
  9. Friedewald WT, Levy RI, Fredrickson DS (1972) In: Tietz (ed) Determination of LDL cholesterol. Text Book of Clinical Biochemistry, New YorkGoogle Scholar
  10. Jacobson TA, Miller M, Schaefer EJ (2007) Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther 29(5):763–777CrossRefGoogle Scholar
  11. Klip A, Leiter LA (1990) Cellular mechanism of action of metformin. Diabetes Care 13(6):696–704CrossRefGoogle Scholar
  12. Koli CO, Onyeto CA, Akpa BP, Ezike AC, Akah PA, Okoye TC (2010) Neuropharmacological evaluation of Annona senegalensis leaves. Afr J Biotechnol 9(49):8435–8444Google Scholar
  13. Konaté AWR, Sawadogo F, Dubruc O, Caillard M (2012) Ouedraogo, Guissou IP. Phytochemical and anticonvulsant properties of Annona senegalen-sis Pers. (Annonaceae), plant used in Burkina folk medicine to treat epilepsy and convulsions. Br J Pharmacol Toxicol 3(5):245–250Google Scholar
  14. Lawal B, Shittu OK, Abubakar AN, Haruna GM, Sani S, Ossai PC (2015) Haematopoetic effect of methanol extract of Nigerian honey bee (Apis mellifera) Propolis in mice. J Coast Life Med 3(8):648–651CrossRefGoogle Scholar
  15. Lawal B, Shittu OK, Oibiokpa FI, Berinyuy EB, Muhammed H (2017) African natural products with potential antioxidants and hepatoprotectives properties: a review. Clin Phytosci 2:23–66.  https://doi.org/10.1186/s40816-016-0037-0 CrossRefGoogle Scholar
  16. Lawal B, Shittu OK, Oibiokpa IF, Mohammed H, Umar SI, Haruna GM (2016) Antimicrobial evaluation, acute and sub-acute toxicity studies of Allium sativum. J Acute Dis 5(4):296–301CrossRefGoogle Scholar
  17. Mustapha A (2013) Annona senegalensis Persoon: a multipurpose shrub, its phytotherapic, phytopharmacological and phytomedicinal uses. Int J Sci Technol 2(12):862–865Google Scholar
  18. Nagmoti DM, Kothavade PS, Bulani VD, Gawali NB, Juvekar AR (2015) Antidiabetic and antihyperlipidemic activity of Pithecellobium dulce (Roxb.) Benth seeds extract in streptozotocin-induced diabetic rats. Euro J Integ Med 7(3):263–273CrossRefGoogle Scholar
  19. Nisbet JC, Sturtevant JM, Prins JB (2004) Metformin and serious adverse effects. Med J Aust 180:53–54 20CrossRefGoogle Scholar
  20. Omonije OO, Saidu AN, Muhammad HL (2019) Anti-diabetic activities of Chromolaena Odorata methanol root extract and its attenuation effect on diabetic induced hepatorenal impairment in rats. Clinical Phytosci 5:23CrossRefGoogle Scholar
  21. Owolabi OJ, Inninh SO, Anaka ON, Iyamu OA (2014) Antidiabetic and hypolipidemic effects of methanol leaf extract of Napoleona vogelii(Lecythidaceae) Hook & Planch on alloxan-induced diabetes mellitus in rats. Trop J Pharm Res 13(11):1908CrossRefGoogle Scholar
  22. Oyedemi SO, Yakubu MT, Afolayan AJ (2011) Antidiabetic activities of aqueous leaves extract of Leonotis leonurus in streptozotocin induced diabetic rats. J Med Plant Res 5:119–125Google Scholar
  23. Rajaei Z, Hadjzadeh MAR, Moradi R, Ghorbani A, Saghebi A (2015) Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Securigera securidaca seeds in streptozotocin-induced diabetic rats. Adv Biomed Res 4:33.  https://doi.org/10.4103/2277-9175.150427 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Ravi K, Ramachandran B, Subramanian S (2004) Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in streptozotocin-induced diabetic rats. Biol Pharm Bull 27:1212–1217CrossRefGoogle Scholar
  25. Rawi SM, Mourad IM, Sayed DA (2011) Biochemical changes in experimental diabetes before and after treatment with Mangifera indica and Psidium guava extracts. Int J Pharm Bio Sci 2:29–41Google Scholar
  26. Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS (1998) The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Diabetes Care 21:701–705CrossRefGoogle Scholar
  27. Samuel EK, Edifofon A, Omolola TF, Kevwe BE, Oluyemisi FK (2016) Annona senegalensis Persoon (Annonaceae): a review of its ethnomedicinal uses, biological activities and phytocompounds. J Pharmacog Phytochem 5(2):211–219Google Scholar
  28. Sharma B, Balomajumder C, Roy P (2008) Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol 46:2376–2383CrossRefGoogle Scholar
  29. Shewasinad A, Bhoumik D, Hishe HZ, Masresha B (2019) Antidiabetic activity of methanol extract and fractions of Thymus schimperi Ronniger leaves in normal and Streptozotocin induce diabetic mice. Iranian J Pharmacol Ther 16:1–8Google Scholar
  30. Thomas MC, Walker MK, Emberson JR, Thomson AG, Lawlor DA, Ebrahim S, When PH (2005) Prevalence of undiagnosed type 2 diabetes and impaired fasting glucose in older British men and women. Diabet Med 22:789–793CrossRefGoogle Scholar
  31. WHO (2017). Monitoring health for the sustainable development goals (SDG) targets. https://www.who.int/gho/en/ Accessed 18 march, 2017
  32. Yusuf AA, Lawal B, Yusuf MA, Omonije YO, Adejoke AA, Raji FH, Wenawo DL (2018) Free radical scavenging, antimicrobial activities and effect of sub-acute exposure to Nigerian Xylopia Aethiopica seed extract on liver and kidney functional indices of albino rat. Iran J Toxicol 12(3):51–58Google Scholar
  33. Zimmet PZ (2017) Diabetes and its drivers: the largest epidemic in human history. Clin Diabetes Endocrinol 3(1):1–8CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of BiochemistryFederal University of TechnologyMinnaNigeria

Personalised recommendations